global
cellular
metabol
intric
tightli
regul
network
pathway
gener
build
block
energi
sustain
life
cell
viral
infect
often
lead
shift
substrat
util
dysregul
metabol
pathway
chang
cellular
energet
facilit
maxim
viral
replic
exemplifi
studi
conduct
human
cytomegaloviru
hcmv
infect
cell
display
augment
cellular
metabol
anaplerot
shift
glucos
convert
precursor
nucleotid
lipid
synthesi
glutamin
util
replenish
tricarboxyl
acid
tca
cycl
addit
viral
induc
chang
overal
metabol
specif
intermedi
pathway
exploit
infect
de
novo
fatti
acid
biosynthesi
shown
manipul
sever
divers
virus
hcmv
dengu
viru
dv
hepat
c
viru
hcv
de
novo
fatti
acid
biosynthesi
pathway
gener
longchain
fatti
acid
palmit
schemat
repres
figur
first
commit
step
pathway
achiev
convers
acetylcoa
malonylcoa
acetylcoa
carboxylas
acc
subsequ
success
condens
reaction
malonylcoa
acetylcoa
catalyz
fatti
acid
synthas
fasn
ultim
gener
fatti
acid
palmit
palmit
contribut
sever
key
biolog
function
protein
palmitoyl
phospholipid
synthesi
energi
product
fig
hcmv
increas
activ
acc
mean
upregul
phospholipid
synthesi
therebi
provid
addit
membran
viral
assembl
similarli
dv
protein
shown
activ
reloc
fasn
site
viral
replic
increas
rate
fatti
acid
synthesi
hcv
shown
upregul
express
two
key
enzym
de
novo
fatti
acid
biosynthesi
pathway
acc
fasn
sterol
regulatori
element
bind
proteinc
srebpc
depend
manner
well
reloc
fasn
site
viral
replic
rna
virus
known
replic
genom
scaffold
intracellular
membran
case
three
virus
increas
de
novo
fatti
acid
biosynthesi
util
increas
phospholipid
synthesi
vaccinia
viru
prototyp
poxviru
use
vaccin
success
erad
smallpox
larg
size
viral
genom
encod
approxim
gene
enabl
viru
replic
sole
cytoplasm
infect
cell
array
viral
encod
protein
includ
mediat
viral
entri
three
tempor
regul
phase
gene
express
genom
replic
matur
virion
morphogenesi
egress
rang
interact
intrins
innat
adapt
defens
host
despit
viru
physic
genet
autonomi
host
nucleu
infect
still
requir
macromolecul
precursor
nucleotid
phospholipid
amino
acid
well
intracellular
membran
host
translat
machineri
comprehens
metabolom
analysi
vacciniainfect
cell
lack
inde
littl
known
vaccinia
viru
manipul
interfac
host
metabolom
bioenerget
machineri
recent
smith
lab
report
vaccinia
induc
pseudo
hypox
state
earli
infect
also
previous
shown
fasn
inhibitor
cerulenin
diminish
viral
yield
suggest
de
novo
fatti
acid
biosynthesi
import
viral
infect
report
expand
analysi
contribut
de
novo
fatti
acid
biosynthesi
vaccinia
viru
replic
inhibit
pathway
impair
product
infecti
viru
manner
partial
rescu
addit
exogen
palmit
mitochondri
import
palmit
appear
import
infect
wherea
exogen
glucos
dispens
suggest
convers
palmit
acetylcoa
rather
glycolyt
process
glucos
drive
tca
cycl
aerob
energi
product
addit
glutamin
essenti
vaccinia
replic
serv
anaplerot
fill
tca
cycl
examin
impair
de
novo
fatti
acid
biosynthesi
affect
infect
reveal
unimped
progress
biochem
stage
infect
modest
reduct
dna
protein
synthesi
dramat
block
virion
assembl
cumul
data
consist
conclus
de
novo
fatti
acid
biosynthesi
essenti
energi
product
rather
phospholipid
synthesi
poxviru
infect
mention
sever
virus
manipul
de
novo
fatti
acid
biosynthesi
pathway
augment
synthesi
phospholipid
increas
avail
intracellular
membran
need
effici
replic
previous
shown
fatti
acid
synthas
fasn
inhibitor
cerulenin
inhibit
viral
yield
suggest
pathway
may
also
import
vaccinia
viru
infect
assess
contribut
pathway
vaccinia
infect
impact
two
addit
pharmacolog
inhibitor
assess
tetradecyloxi
acid
tofa
inhibit
cellular
enzym
acc
fasn
respect
fig
cell
infect
wt
vaccinia
viru
treat
vehicl
control
dmso
tofa
h
treatment
tofa
significantli
inhibit
viral
yield
respect
fig
black
bar
valid
specif
inhibitor
test
abil
endproduct
de
novo
fatti
acid
biosynthet
pathway
palmit
revers
impact
palmit
acid
coupl
fattyacid
free
bovin
serum
albumin
exogen
palmit
ad
infect
cell
treat
dmso
tofa
describ
addit
palmit
impact
cell
treat
dmso
rescu
viral
yield
cell
treat
either
tofa
fig
gray
bar
immunoblot
analysi
lysat
prepar
cell
infect
condit
show
accumul
viral
earli
protein
unaffect
inhibitor
test
howev
decreas
accumul
viral
late
protein
decreas
cleavag
viral
protein
hallmark
virion
assembl
inhibitor
effect
amelior
addit
exogen
palmit
data
shown
taken
togeth
data
show
de
novo
fatti
acid
biosynthet
pathway
palmit
specif
import
maximum
viral
product
palmit
sever
biolog
function
within
cell
shown
figur
protein
palmitoyl
phospholipid
synthesi
energi
product
via
determin
palmit
util
palmitoyl
cell
infect
presenc
vehicl
dmso
variou
concentr
palmit
analogu
impair
palmitoyl
inhibit
palmitoyl
acyl
transferas
inclus
impact
h
viral
yield
fig
wherea
coronaviru
replic
inhibit
valid
efficaci
inhibitor
hand
cell
incub
palmit
h
presenc
dmso
whole
cell
lysat
resolv
analyz
fluorographi
expect
level
palmitoyl
protein
greatli
decreas
sampl
fig
next
determin
whether
util
palmit
phospholipid
synthesi
import
viral
replic
assess
impact
pharmacolog
inhibitor
triacsin
c
triacsin
c
potent
competit
inhibitor
long
chain
acylcoa
synthetas
thu
prevent
acyl
long
chain
fatti
acid
henc
initi
phospholipid
synthesi
treatment
triacsin
c
impact
h
viral
yield
fig
valid
efficaci
inhibitor
cell
incub
oleic
acid
presenc
dmso
triacsin
c
stain
monitor
inclus
oleic
acid
lipid
droplet
process
requir
acyl
oleic
acid
acylcoa
synthetas
treatment
triacsin
c
abrog
format
lipid
droplet
fig
note
concentr
triacsin
c
previous
shown
inhibit
rotaviru
replic
taken
togeth
data
indic
import
palmit
synthesi
fatti
acid
biosynthesi
gener
vaccinia
infect
independ
contribut
protein
modif
phospholipid
synthesi
data
present
suggest
key
contribut
palmit
vaccinia
infect
might
potenti
undergo
promot
energi
product
first
approach
understand
bioenerget
pathway
contribut
product
viral
infect
test
import
glucos
metabol
pyruv
ultim
acetylcoa
therebi
drive
tca
cycl
cell
therefor
infect
wt
vaccinia
viru
glucosefre
media
media
supplement
mm
glucos
fig
gray
black
respect
surprisingli
absenc
glucos
impact
h
viral
yield
suggest
infect
cell
might
reli
drive
tca
cycl
oxid
phosphoryl
rather
glycolysi
provid
energi
directli
test
hypothesi
infect
cell
reli
import
util
palmit
within
mitochondria
cell
infect
presenc
vehicl
solid
bar
pharmacolog
inhibitor
etomoxir
stripe
bar
etomoxir
irrevers
inhibitor
carnitin
palmitoyltransferas
prevent
import
longchain
fatti
acid
mitochondria
treatment
etomoxir
inhibit
h
viral
yield
compar
treatment
dmso
fig
left
bar
expect
base
mode
action
etomoxir
addit
exogen
palmit
unabl
rescu
viral
yield
data
shown
intim
feedback
variou
facet
cellular
metabol
illustr
observ
inhibit
caus
concomit
increas
glycolyt
pathway
light
interrelated
impact
etomoxir
treatment
viral
replic
cell
maintain
absenc
glucos
also
examin
glucos
omit
medium
treatment
etomoxir
caus
much
greater
decreas
viral
yield
seen
glucosecontain
media
fig
right
bar
data
show
import
longchain
fatti
acid
mitochondria
import
viral
infect
formal
test
hypothesi
viru
infect
requir
longchain
fatti
acid
within
mitochondria
energi
product
cell
infect
presenc
variou
concentr
pharmacolog
inhibitor
trimetazidin
tmz
tmz
competit
inhibitor
coenzym
thiolas
key
enzym
inclus
mm
tmz
led
dosedepend
modest
decreas
h
viral
yield
cell
maintain
presenc
glucos
decreas
mm
fig
black
diamond
seen
etomoxir
fig
treatment
tmz
absenc
glucos
caus
dosedepend
sever
inhibit
viral
yield
decreas
mm
fig
gray
circl
taken
togeth
data
show
import
palmit
mitochondria
subsequ
import
viral
infect
addit
presenc
glucos
import
viral
replic
unless
fatti
acid
inhibit
suggest
tca
cycl
within
infect
cell
normal
driven
acetylcoa
gener
palmit
rather
glycolysi
altern
glycolysi
process
glutaminolysi
provid
tca
cycl
intermedi
deamin
glutamin
glutam
import
mitochondria
convert
evalu
import
glutamin
viral
infect
cell
infect
wt
vaccinia
viru
glutaminefre
media
media
supplement
variou
concentr
glutamin
fig
absenc
glutamin
viral
yield
reduc
addit
glutamin
rescu
viral
yield
respect
maximum
viru
product
restor
mm
glutamin
determin
whether
tca
cycl
sustain
anaplerot
util
glutamin
cell
infect
wt
vaccinia
viru
glutaminefre
medium
media
supplement
tca
cycl
intermedi
oxaloacet
diagon
stripe
bar
horizont
stripe
bar
fig
absenc
glutamin
addit
mm
oxaloacet
unabl
rescu
viral
yield
mm
rescu
viral
yield
presenc
glutamin
rescu
viral
yield
addit
mm
oxaloacet
mm
led
addit
increas
viru
product
respect
taken
togeth
data
demonstr
glutamin
play
critic
role
infect
among
anaplerot
support
tca
cycl
sustain
exogen
suppli
oxaloacet
sinc
appear
key
role
palmit
viral
infect
drive
tca
cycl
energi
product
atp
synthesi
monitor
cours
infect
util
seahors
bioscienc
extracellular
flux
analyz
measur
oxygen
consumpt
rate
direct
surrog
atp
synthesi
assay
allow
repeat
monitor
atp
synthesi
singl
sampl
time
cell
plate
densiti
cell
per
well
dish
either
mock
infect
infect
wt
vaccinia
viru
oxygen
consumpt
rate
measur
everi
min
min
h
postinfect
hpi
min
post
infect
mock
treat
cell
oxygen
consumpt
rate
ocr
pmolmin
rose
pmolmin
hpi
nutrient
consum
fig
gray
line
strikingli
initi
ocr
min
postinfect
wt
infect
cell
almost
twice
mock
infect
cell
pmolmin
rate
remain
high
throughout
infect
rise
pmolmin
hpi
fig
black
line
statist
analysi
indic
ocr
significantli
higher
infect
cell
mockinfect
cell
time
point
linear
regress
analysi
indic
rate
increas
ocr
hour
measur
also
significantli
higher
infect
cell
measur
mockinfect
cell
extracellular
acidif
rate
readout
lactat
product
remain
larg
unchang
time
data
shown
increas
ocr
ascrib
mitochondri
rather
glycolyt
activ
confirm
elev
ocr
seen
infect
cell
due
increas
palmit
tca
cycledriven
atp
product
cell
infect
wt
viru
presenc
vehicl
etomoxir
subject
seahors
analysi
dmsotreat
cell
ocr
time
cours
similar
slope
seen
fig
black
line
ocr
measur
etomoxirtr
cell
depress
time
decreas
cours
infect
fig
gray
line
taken
togeth
data
show
even
min
post
infect
oxygen
consumpt
rate
henc
atp
synthesi
increas
almost
mock
treat
cell
increas
maintain
throughout
infect
loss
oxygen
consumpt
seen
presenc
etomoxir
confirm
mitochondri
import
longchain
fatti
acid
key
sustain
elev
atp
product
within
infect
cell
previous
fasn
report
diffus
local
within
cell
assess
immunofluoresc
microscopi
fasn
shown
reloc
site
viral
replic
cell
infect
dv
hcv
util
varieti
commerci
avail
antibodi
monitor
local
fasn
uninfect
vacciniainfect
cell
hpi
immunofluoresc
microscopi
reproduc
distinct
pattern
seen
use
polyclon
antibodi
rais
peptid
fasn
mockinfect
cell
fig
left
column
tubular
pattern
stain
radiat
throughout
cytoplasm
seen
pattern
reminisc
mitochondri
stain
inde
antifasn
stain
pattern
larg
coloc
mitotrack
signal
merg
fourth
row
zoom
bottom
row
pearson
coeffici
valid
specif
stain
seen
antifasn
antibodi
obtain
block
cell
peptid
use
immunogen
presenc
block
peptid
antifasn
stain
seen
fig
middl
column
although
mitotrack
mitochondria
dapi
nuclei
stain
remain
unchang
hpi
vaccinia
viru
pattern
antifasn
stain
quit
similar
remain
coincid
mitotrack
profil
pearson
coeffici
although
fasn
mitochondria
concentr
perinuclear
region
cell
fig
right
column
data
show
least
portion
fasn
portion
access
antifasn
antibodi
local
near
mitochondria
suggest
palmit
may
gener
fasn
close
proxim
mitochondria
facilit
import
cumul
data
shown
indic
product
mitochondri
import
palmit
import
product
vaccinia
infect
first
step
determin
stage
viral
life
cycl
affect
inhibitor
analyz
viral
dna
replic
percel
basi
fig
cell
infect
wt
vaccinia
viru
presenc
brdu
incorpor
newli
synthes
dna
treat
dmso
tofa
etomoxir
h
cell
stain
antisera
brdu
mark
site
nascent
viral
dna
synthesi
fig
second
row
viral
singlestrand
dna
bind
protein
fig
top
row
dapi
stain
dna
fig
middl
row
cell
treat
vehicl
dmso
left
column
larg
site
viral
dna
replic
accumul
cytoplasm
shown
coloc
brdu
merg
fourth
row
zoom
bottom
row
similar
replic
foci
observ
cell
treat
either
tofa
middl
column
etomoxir
right
column
indic
genom
replic
proceed
presenc
inhibitor
note
replic
foci
drugtreat
cell
appear
somewhat
smaller
numer
examin
integr
viral
dna
accumul
presenc
variou
drug
pulsedfield
gel
electrophoresi
employ
fig
cell
infect
wt
viru
presenc
dmso
tofa
etomoxir
h
dna
resolv
visual
ethidium
bromid
fulllength
viral
genom
kbp
arrowhead
predomin
treatment
although
level
dna
accumul
diminish
wt
level
presenc
tofa
etomoxir
respect
similar
result
seen
viral
dna
replic
assay
southern
dot
blot
analysi
data
shown
cumul
data
show
viral
dna
replic
modestli
impair
palmit
synthesi
mitochondri
import
impair
sinc
dna
replic
accomplish
earli
viral
protein
sinc
analysi
fig
immunoblot
assay
shown
indic
protein
accumul
high
level
presenc
drug
conclud
earli
protein
synthesi
also
larg
unaffect
inhibitor
vaccinia
viru
infect
character
tempor
regul
cascad
gene
express
phase
transcript
earli
intermedi
late
mediat
protein
express
prior
phase
moreov
infect
progress
host
transcript
quell
host
mrna
decreas
abund
translat
skew
toward
viral
mrna
therefor
assess
whether
progress
robust
viral
protein
synthesi
impair
cycl
palmit
synthesi
mitochondri
import
disrupt
cell
mockinfect
infect
wt
vaccinia
viru
presenc
vehicl
dmso
tofa
etomoxir
puls
label
methionin
min
indic
time
postinfect
illustr
autoradiograph
shown
fig
protein
synthesi
mockinfect
cell
larg
unaffect
inclus
inhibitor
lane
h
posttreat
lane
h
posttreat
except
tofatr
cell
protein
synthesi
reduc
h
posttreat
lane
infect
cell
saw
expect
reduct
host
protein
synthesi
hpi
lane
intermedi
viral
protein
readili
seen
hpi
circl
lane
treatment
although
synthesi
level
somewhat
decreas
cell
treat
tofa
etomoxir
control
level
respect
synthesi
late
viral
protein
star
lane
occur
treatment
although
reduct
level
express
seen
drugtreat
cell
overal
protein
synthesi
diminish
control
level
cell
treat
tofa
cell
treat
either
etomoxir
data
show
inhibit
palmit
synthesi
mitochondri
import
lead
modest
reduct
rate
protein
synthesi
impair
host
shutoff
progress
characterist
phase
vaccinia
gene
express
next
analyz
process
viral
morphogenesi
determin
inhibit
de
novo
fatti
acid
biosynthesi
affect
format
matur
virion
focu
morphogenesi
without
complic
minor
impact
inhibitor
exert
protein
synthesi
genom
accumul
took
two
experiment
approach
first
util
temperaturesensit
mutant
lesion
protein
kinas
nonpermiss
temperatur
viru
wellcharacter
defect
viru
assembl
viral
genom
replic
full
cycl
gene
express
proceed
normal
infect
arrest
prior
membran
biogenesi
arrest
revers
cell
shift
permiss
condit
cell
infect
h
nonpermiss
condit
releas
permiss
condit
allow
resumpt
assembl
releas
perform
h
presenc
vehicl
dmso
inhibitor
rifampicin
rif
allow
membran
biogenesi
move
forward
block
format
immatur
matur
virion
tofa
viral
yield
cell
shift
permiss
condit
presenc
dmso
greater
yield
cell
shift
condit
viru
product
inhibit
rif
fig
interestingli
inclus
tofa
temperatur
shift
deleteri
viru
product
rifampicin
data
strongli
suggest
de
novo
fatti
acid
biosynthesi
extrapol
atp
product
particularli
import
virion
assembl
examin
import
fatti
acid
biosynthesi
viral
assembl
perform
infect
presenc
rifampicin
revers
inhibitor
rifampicin
prevent
interact
viral
protein
therebi
prevent
assembl
immatur
virion
presenc
rif
dna
replic
full
profil
protein
express
proceed
normal
morphogenesi
arrest
earli
stage
cell
infect
wt
vaccinia
viru
presenc
rif
h
wash
fresh
media
incub
anoth
h
presenc
rif
neg
control
inhibit
resumpt
assembl
dmso
posit
control
allow
full
recoveri
tofa
fig
cell
releas
rif
block
dmso
produc
viru
maintain
rif
cell
treat
tofa
impair
recoveri
seen
viral
product
greater
observ
cultur
maintain
rif
black
bar
addit
palmit
gave
signific
incomplet
rescu
viru
product
cell
releas
rif
presenc
gray
bar
shown
tofa
impair
virion
assembl
even
ad
dna
replic
late
gene
express
accomplish
electron
microscop
analysi
perform
cell
infect
presenc
rif
h
releas
rif
dmso
describ
fig
phenotyp
seen
cell
maintain
rif
expect
flaccid
membran
arrowhead
accumul
around
electrondens
virosom
v
fig
upper
left
membran
lack
exterior
scaffold
henc
show
spike
appear
normal
virion
membran
progress
typic
crescent
immatur
matur
virion
found
cell
releas
dmso
upper
right
panel
full
rang
assembl
intermedi
includ
crescent
c
immatur
virion
iv
matur
virion
shown
seen
cell
releas
lower
panel
novel
block
assembl
seen
crescent
membran
iv
membran
peanut
shape
membran
open
circl
resembl
two
fuse
iv
seen
howev
smooth
dens
viroplasm
observ
rif
synchron
dispers
splotch
aggreg
star
enclos
iv
membran
open
diamond
mani
iv
howev
appear
devoid
interior
content
matur
virion
seen
consist
data
shown
fig
addit
exogen
palmit
treat
cell
partial
rescu
block
observ
cell
treat
alon
data
shown
taken
togeth
data
show
de
novo
fatti
acid
biosynthesi
import
virion
assembl
even
constitu
compon
present
dramat
impair
observ
fragment
virosom
content
splotchi
aggreg
ineffici
incorpor
materi
nascent
virion
membran
data
present
support
model
depict
schemat
figur
de
novo
fatti
acid
biosynthet
pathway
compris
two
enzym
acc
fasn
gener
palmit
within
cytoplasm
palmit
import
mitochondria
undergo
gener
acetylcoa
gener
acetylcoa
palmit
rather
glucos
drive
tca
cycl
gener
suffici
amount
atp
maxim
viral
product
inhibit
part
pathway
caus
signific
diminut
viral
yield
atp
gener
pathway
contribut
viral
dna
replic
protein
synthesi
import
morphogenesi
infecti
virion
glucos
larg
dispens
infect
glutamin
essenti
major
role
glutamin
enabl
anaplerot
support
tca
cycl
via
deamin
glutam
within
cytoplasm
convers
within
mitochondria
success
activ
glutaminas
glutam
dehydrogenas
robust
action
tca
cycl
may
allow
shuttl
citrat
cytoplasm
gener
pool
acetylcoa
synthesi
palmit
previous
shown
fasn
inhibitor
cerulenin
impair
vaccinia
viru
morphogenesi
began
current
studi
expect
de
novo
fatti
acid
biosynthesi
would
need
augment
intracellular
membran
avail
support
viral
assembl
howev
expect
support
experiment
exampl
triacsin
c
inhibit
long
chain
acylcoa
synthetas
drastic
impair
phospholipid
synthesi
impact
vaccinia
viru
infect
fig
cerulenin
tofa
inhibit
vaccinia
viru
infect
consid
role
endproduct
activ
palmit
might
play
abl
discard
essenti
role
protein
palmitoyl
progress
life
cycl
demonstr
infect
resist
fig
sever
viral
protein
undergo
palmitoyl
includ
protein
shown
particip
matur
small
subset
matur
virion
mv
extracellular
virion
ev
studi
focus
product
mv
constitut
vast
major
virion
suffici
infect
tissu
cultur
third
key
role
palmit
undergo
within
mitochondria
gener
acetylcoa
key
compon
tca
cycl
turn
drive
oxid
phosphoryl
atp
gener
seem
intuit
vaccinia
infect
would
requir
high
level
atp
given
robust
synthesi
viral
rna
dna
protein
assembl
larg
number
complex
virion
found
glucos
dispens
infect
fig
moreov
also
found
oxygen
consumpt
surrog
measur
mitochondri
atp
synthesi
elev
significantli
infect
cell
fig
observ
consist
previou
report
demonstr
increas
atp
level
vacciniainfect
hela
cell
data
indic
optim
infect
requir
synthesi
mitochondri
import
palmit
fig
note
complet
oxid
one
molecul
palmit
yield
atp
gener
one
molecul
glucos
atp
atp
even
consid
fact
gener
palmit
requir
atp
atp
gener
activ
acetylcoa
atp
complet
condens
reaction
palmit
yield
twice
amount
atp
compar
glucos
interestingli
valu
correl
increas
ocr
observ
upon
infect
vaccinia
viru
thu
least
cell
vaccinia
viru
depend
upon
fatti
acid
within
mitochondria
glycolysi
maxim
atp
product
alter
metabol
profil
earli
event
infect
sinc
ocr
level
alreadi
high
hpi
fig
determin
mitochondri
activ
stimul
earli
infect
area
interest
futur
studi
given
central
role
fasn
gener
palmit
consid
vaccinia
might
exploit
maxim
activ
hcv
shown
upregul
express
enzym
involv
fatti
acid
synthesi
howev
level
fasn
upregul
vaccinia
infect
data
shown
interest
futur
determin
whether
specif
activ
acc
fasn
upregul
upon
vaccinia
infect
sinc
enzym
known
modul
phosphoryl
ubiquitin
specif
interact
stimulatori
inhibitori
bind
partner
dv
hcv
induc
chang
local
fasn
site
rna
replic
local
fasn
appear
chang
vaccinia
infect
success
detect
stabl
andor
obviou
interact
fasn
vacciniaencod
protein
shown
howev
surpris
see
cell
signific
portion
fasn
coloc
mitochondria
fig
coloc
report
reason
conclud
proxim
would
facilit
mitochondri
import
palmit
immedi
synthesi
electron
microscop
analysi
vacciniainfect
cell
reveal
mitochondria
numer
peripheri
viral
factori
may
facilit
deliveri
atp
viral
machineri
de
novo
fatti
acid
biosynthet
pathway
driven
acc
fasn
requir
ampl
concentr
acetylcoa
gener
via
two
primari
pathway
first
mechan
involv
catabol
pyruv
pyruv
dehydrogenas
unlik
howev
sinc
recent
report
pseudohypox
state
induc
earli
vaccinia
infect
lead
upregul
gene
caus
increas
flux
glucos
lactat
concomit
decreas
accumul
acetylcoa
mitochondria
second
mechan
involv
catabol
citrat
acetylcoa
oxaloacet
atp
citrat
lyas
acli
pathway
util
highli
prolif
cell
util
citrat
intermedi
lipogen
pathway
order
tca
cycl
slow
result
divers
citrat
fatti
acid
synthesi
replenish
must
occur
hcmvinfect
cell
replenish
tca
cycl
shown
occur
glutaminolysi
anaplerosi
glutaminolysi
refer
use
glutamin
sourc
ultim
synthesi
subsequ
util
synthesi
citrat
inde
glutamin
essenti
vaccinia
viru
infect
deplet
glutamin
reduc
viral
yield
fig
oxaloacet
fill
tca
cycl
abl
rescu
viral
yield
significantli
albeit
presenc
low
concentr
glutamin
fig
suggest
citrat
may
inde
provid
acetylcoa
need
cytoplasm
vacciniainfect
cell
palmit
synthesi
metabolom
studi
aim
determin
chang
level
acetylcoa
malonylcoa
palmit
tca
cycl
intermedi
vaccinia
infect
highli
inform
perhap
surpris
product
viral
infect
requir
low
level
glutamin
rescu
tca
cycl
intermedi
glutamin
known
play
role
purin
pyrimidin
synthesi
well
protein
synthesi
studi
indic
progress
viral
life
cycl
three
tempor
regul
stage
gene
express
process
viral
dna
synthesi
matur
impair
presenc
tofa
etomoxir
observ
mild
decreas
level
genom
accumul
fig
modest
decreas
level
protein
synthes
fig
even
tofa
ad
hpi
biosynthet
process
larg
complet
signific
impact
viru
product
process
virion
morphogenesi
appear
acut
sensit
impact
drug
attend
decreas
atp
synthesi
demonstr
use
rifampicin
arrest
cell
onset
morphogenesi
monitor
viru
product
block
releas
fig
b
cell
releas
tofa
expect
burst
viru
product
diminish
util
electron
microscopi
visual
assembl
process
synchron
rifampicin
h
releas
vehicl
alon
addit
h
fig
cell
releas
vehicl
alon
saw
full
spectrum
assembl
intermedi
includ
crescent
c
immatur
virion
iv
immatur
virion
nucleoid
ivn
matur
virion
mv
imag
seen
upon
releas
strikingli
differ
flaccid
membran
accumul
presenc
rifampicin
inde
chase
normal
crescent
membran
associ
scaffold
protein
mani
crescent
enlarg
resembl
iv
although
signific
number
peanut
shape
reminisc
two
iv
fuse
togeth
howev
iv
crescent
empti
associ
smooth
virosom
materi
larg
virosom
accumul
presenc
rifampicin
dispers
fragment
aggreg
solubl
virosom
protein
compromis
phenotyp
quit
distinct
observ
suggest
solubl
virosom
protein
inclus
nascent
virion
highli
depend
upon
suffici
atp
level
sum
data
support
conclus
de
novo
fatti
acid
biosynthet
pathway
play
key
role
viral
infect
gener
suffici
palmit
import
mitochondria
subsequ
palmit
drive
tca
cycl
augment
product
atp
data
gener
use
seahors
technolog
confirm
atp
product
highli
elev
within
infect
cell
manner
depend
upon
mitochondri
fatti
acid
import
thu
vaccinia
infecti
cycl
highli
depend
upon
cellular
bioenerget
moreov
infect
seem
shift
cellular
metabol
toward
oxid
less
glycolyt
state
de
novo
fatti
acid
biosynthesi
pathway
offer
novel
target
develop
therapeut
treat
poxviru
infect
interestingli
biochem
pathway
often
upregul
cancer
inhibitor
target
pathway
tofa
cerulenin
inhibit
cancer
cell
prolifer
vitro
new
compound
develop
retain
efficaci
show
increas
solubl
reduc
toxic
fasn
inhibitor
interest
determin
compound
would
antipoxvir
efficaci
tissu
cultur
anim
model
methionin
palmit
purchas
perkin
elmer
life
scienc
boston
label
protein
molecular
weight
marker
mitotrack
red
cmxro
purchas
invitrogen
carlsbad
ca
protran
nitrocellulos
membran
obtain
ge
healthcar
life
scienc
buckinghamshir
uk
tetradecyloxi
acid
tofa
triacsin
c
obtain
enzo
life
scienc
trimetazidin
rifampicin
fattyacid
free
bovin
serum
albumin
sodium
palmit
oleic
acid
glucos
glutamin
oxaloacet
acid
obtain
sigma
saint
loui
mo
etomoxir
obtain
tocri
bioscienc
bristol
uk
cell
infect
moi
incub
nonpermiss
temperatur
h
cell
shift
permiss
temperatur
h
presenc
tofa
rif
vehicl
alon
dmso
follow
analysi
viral
yield
protein
accumul
ii
altern
cell
infect
wt
viru
moi
incub
h
presenc
rif
rifampicin
wash
cell
treat
fresh
media
contain
rif
tofa
vehicl
alon
dmso
well
exogen
palmit
acid
indic
incub
h
harvest
analyz
viral
yield
protein
express
cell
seed
infect
cell
wash
glucosefre
media
gibco
incub
h
glucosefre
media
glucosefre
media
supplement
mm
glucos
cell
harvest
analyz
viral
yield
ii
cell
seed
infect
cell
wash
glutaminefre
media
gibco
incub
h
glutaminefre
media
glutaminefre
media
supplement
variou
concentr
glutamin
mm
oxaloacet
mm
acid
cell
harvest
analyz
viral
yield
cell
seed
cell
per
well
pet
tissu
cultur
plate
seahors
bioscienc
incub
h
cell
either
mock
infect
infect
wt
vaccinia
viru
moi
addit
cell
infect
wt
vaccinia
viru
treat
etomoxir
vehicl
control
durat
experi
prior
experi
cell
incub
min
high
glucos
dmem
gibco
lack
sodium
bicarbon
supplement
mm
hepe
gibco
drug
appropri
oxygen
consumpt
rate
measur
everi
minut
use
seahors
bioscienc
extracellular
flux
analyz
seahors
bioscienc
hpi
data
assay
quadrupl
three
separ
day
graph
microsoft
excel
error
bar
repres
standard
error
mean
linear
regress
analysi
employ
show
statist
differ
sampl
group
hpi
cell
treat
mitotrack
red
nm
h
cell
wash
twice
cold
pb
ice
fix
cold
min
ice
wash
twice
cold
pb
cell
permeabil
saponin
buffer
bsa
glycin
saponin
pb
h
room
temperatur
sampl
stain
polyclon
antifasn
abcam
antiserum
dilut
saponin
buffer
follow
secondari
antibodi
conjug
goat
antirabbit
igg
invitrogen
dilut
saponin
buffer
dapi
ad
min
room
temperatur
indic
fasn
block
peptid
mgml
abcam
incub
saponin
buffer
polyclon
antifasn
antiserum
sampl
mount
vectashield
vector
laboratori
inc
burlingam
ca
pictur
captur
use
nikon
eclips
microscop
nisel
softwar
tokyo
japan
pearson
coeefici
util
measur
degre
coloc
fasn
mitotrack
viral
infect
cell
maintain
presenc
bromodeoxyuridin
brdu
well
vehicl
dmso
tofa
etomoxir
cell
wash
twice
cold
pb
ice
fix
cold
paraformaldehyd
pb
min
ice
wash
twice
cold
pb
cell
permeabil
pb
min
ice
sampl
stain
monoclon
antibrdu
development
studi
hybridoma
bank
univers
iowa
iowa
citi
ia
polyclon
antibodi
follow
secondari
antibodi
conjug
either
alexafluor
goat
antimous
igg
alexafluor
goat
antirabbit
igg
invitrogen
dapi
ad
min
room
temperatur
cell
mount
pictur
captur
describ
confluent
chamber
slide
cell
treat
oleic
acid
induc
lipid
droplet
format
absenc
presenc
triacsin
c
h
cell
wash
twice
cold
pb
fix
cold
paraformaldehyd
pb
min
wash
twice
cold
pb
cell
permeabil
pb
min
ice
stain
life
technolog
ny
h
room
temperatur
dapi
ad
min
room
temperatur
slide
mount
pictur
captur
describ
confluent
monolay
cell
pretreat
dmso
h
cell
wash
twice
ml
wash
medium
dmem
dialyz
fb
mgml
fatti
acidfre
bsa
mm
sodium
pyruv
incub
medium
supplement
mciml
palmit
h
cell
harvest
ice
wash
cold
pb
lyse
ripa
buffer
mm
tri
ph
mm
nacl
mm
edta
sodium
deoxychol
sd
glycerol
proteas
inhibitor
min
ice
whole
cell
lysat
resolv
sdspage
visual
fluorographi
confluent
mm
dish
cell
infect
wt
vaccinia
viru
moi
h
presenc
vehicl
control
tofa
etomoxir
cell
pellet
process
describ
earlier
briefli
cell
pellet
embed
lowmeltingpoint
agaros
digest
h
mild
agit
esp
buffer
sarcosyl
edta
ph
mgml
proteinas
k
plug
equilibr
tbe
buffer
prior
insert
premold
well
seakem
gold
agaros
gel
cast
resolv
buffer
dna
resolv
chef
mapper
xa
apparatu
biorad
vcm
hour
use
switch
time
gradient
second
ramp
factor
nonlinear
angl
dna
visual
ethidium
bromid
stain
imag
captur
quantifi
use
alphaview
softwar
proteinsimpl
confluent
mm
dish
cell
infect
wt
viru
moi
mock
infect
treat
tofa
etomoxir
vehicl
control
cell
rins
methioninefre
dmem
puls
methionin
min
either
hpi
hpi
cell
harvest
rins
pb
contain
proteas
inhibitor
resuspend
pb
contain
psb
proteas
inhibitor
resolv
acrylamid
gel
gel
stain
coomassi
brilliant
blue
subject
autoradiographi
effect
protein
synthesi
quantifi
measur
radioact
present
lane
use
typhoon
fla
imag
imag
quant
tl
imag
softwar
ge
healthcar
bioscienc
pittsburgh
pa
signal
experiment
lane
normal
dmso
control
sampl
time
point
confluent
mm
dish
cell
infect
wt
viru
presenc
rifampicin
releas
describ
eight
hour
post
releas
sampl
fix
situ
glutaraldehyd
sorensen
phosphat
buffer
ph
process
epoxi
embed
convent
transmiss
electron
microscopi
section
examin
jeol
jem
electron
microscop
digit
imag
acquir
use
gatan
ultrascan
camera
origin
data
scan
epson
perfect
scanner
long
beach
ca
adjust
adob
photoshop
softwar
adob
system
inc
san
jose
ca
statist
analysi
graph
prepar
perform
use
sigmaplot
softwar
systat
softwar
chicago
il
graphpad
prism
la
jolla
ca
final
figur
assembl
label
canva
softwar
deneba
system
miami
fl
